Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B10 | O60218 | 7/20 | 0.65 |
| ▸ | AKR1B1 | P15121 | 7/20 | 0.65 |
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | MAOB | P27338 | 1/20 | 0.55 |
| ▸ | APP | P05067 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.51 |
| ▸ | CA4 | P22748 | 1/20 | 0.51 |
| ▸ | CA6 | P23280 | 1/20 | 0.51 |
| ▸ | CA5A | P35218 | 1/20 | 0.51 |
| ▸ | CA7 | P43166 | 1/20 | 0.51 |
| ▸ | CA9 | Q16790 | 1/20 | 0.51 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.51 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.51 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | GMNN | O75496 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL144598 | 1.00 | AKR1B10 (0.65) | AKR1B10AKR1B1LMNAMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL143255 | 0.98 | AKR1B10 (0.63) | AKR1B10AKR1B1LMNAMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL143254 | 0.98 | AKR1B10 (0.63) | AKR1B10AKR1B1LMNAMEN1KMT2A | |
| SCHEMBL7997845 | 0.95 | AKR1B10 (0.63) | AKR1B10AKR1B1LMNAMEN1KMT2A | |
| SCHEMBL7997849 | 0.95 | AKR1B10 (0.63) | AKR1B10AKR1B1LMNAMEN1KMT2A | |
| SCHEMBL8009699 | 0.94 | AKR1B10 (0.61) | AKR1B10AKR1B1LMNAMEN1KMT2A | |
| SCHEMBL8007280 | 0.94 | AKR1B10 (0.61) | AKR1B10AKR1B1LMNAMEN1KMT2A | |
| SCHEMBL8008069 | 0.94 | AKR1B10 (0.61) | AKR1B10AKR1B1LMNAMEN1KMT2A | |
| SCHEMBL7997837 | 0.94 | AKR1B10 (0.61) | AKR1B10AKR1B1LMNAMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL1746110 | 0.94 | AKR1B10 (0.61) | AKR1B10AKR1B1LMNAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11779593-B2 | Agent for improving ocular subjective symptoms and method thereof | SEIKAGAKU CORPORATION (JP) | 2023-10-10 | — | — | US | claimed |
| US-20220105125-A1 | AGENT FOR IMPROVING OCULAR SUBJECTIVE SYMPTOMS AND METHOD THEREOF | SEIKAGAKU CORPORATION (JP) | 2022-04-07 | — | — | US | claimed |
| US-20210380727-A1 | NOVEL PHOTOCROSSLINKABLE ALGINIC ACID DERIVATIVE | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2021-12-09 | — | — | US | claimed |
| EP-3760647-A1 | NOVEL PHOTOCROSSLINKABLE ALGINIC ACID DERIVATIVE | Mochida Pharmaceutical Co., Ltd. (JP) | 2021-01-06 | — | — | EP | claimed |
| CN-111918881-A | Novel photocrosslinkable alginic acid derivative | 持田制药株式会社 | 2020-11-10 | — | — | CN | claimed |
| US-9301972-B2 | Hyaluronic acid derivatives | SEIKAGAKU CORPORATION (JP) | 2016-04-05 | — | — | US | claimed |
| US-20150094280-A1 | PHARMACEUTICAL AGENT HAVING LONG-LASTING EFFECT OF TREATING ARTHRITIC DISORDERS | SEIKAGAKU CORPORATION (JP) | 2015-04-02 | — | — | US | claimed |
| US-8536317-B2 | Crosslinked polysaccharide sponge | SEIKAGAKU CORPORATION (JP) | 2013-09-17 | — | — | US | claimed |
| US-8389713-B2 | Polysaccharide pseudo-sponge | SEIKAGAKU CORPORATION (JP) | 2013-03-05 | — | — | US | claimed |
| US-20120055780-A1 | POLYSACCHARIDE PSEUDO-SPONGE | SEIKAGAKU CORPORATION (JP) | 2012-03-08 | — | — | US | claimed |
| US-20110098455-A1 | Crosslinked polysaccharide sponge | SEIKAGAKU CORPORATION (JP) | 2011-04-28 | — | — | US | claimed |
| US-7893225-B2 | Formed by freezing photoreactive polysaccharide (hyaluronic acids) solution, then irradiating to crosslink; requires no removal of solvent | SEIKAGAKU CORPORATION (JP) | 2011-02-22 | — | — | US | claimed |
| US-11779593-B2 | Agent for improving ocular subjective symptoms and method thereof | SEIKAGAKU CORPORATION (JP) | 2023-10-10 | — | — | US | disclosed |
| US-20220370630-A1 | TRANSMUCOSAL DELIVERY SYSTEM FOR PHARMACEUTICAL ACTIVE INGREDIENT TO SUBMUCOSAL TISSUE OF BLADDER | SEIKAGAKU CORPORATION (JP) | 2022-11-24 | — | — | US | disclosed |
| US-11472891-B2 | Photocrosslinkable alginic acid derivative | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2022-10-18 | — | — | US | disclosed |
| CN-111918881-B | Novel photocrosslinkable alginic acid derivative | 持田制药株式会社 | 2022-08-12 | — | — | CN | disclosed |
| US-6025444-A | HYALURONIC ACID POLYSACCHARIDE DERIVATIVE; PHOTODIMERIZABLE, CROSSLINKABLE | SEIKAGAKU KOGYO KABUSHIKI KAISHA (SEIKAGAKU CORPORATION) (JP) | 2000-02-15 | — | — | US | disclosed |
| CN-1037511-C | Therapeutic agents | BOOTS CO PLC (GB) | 1998-02-25 | — | — | CN | disclosed |
| EP-0713859-A2 | Cinnamic acid derivatives, photocrosslinkable cinnamic acid-polymer derivative and crosslinked cinnamic acid polymer derivatives | SEIKAGAKU KOGYO KABUSHIKI KAISHA (SEIKAGAKU CORPORATION) (JP) | 1996-05-29 | — | — | EP | disclosed |
| CN-1096781-A | The therapeutical agent that contains 1-(aralkyl-aminoalkyl) imidazolium compounds | BOOTS CO PLC (GB) | 1994-12-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220370630-A1 | TRANSMUCOSAL DELIVERY SYSTEM FOR PHARMACEUTICAL ACTIVE INGREDIENT TO SUBMUCOSAL TISSUE OF BLADDER | PIGS, MMP7, CD44 | AKR1B10 1825/4885AKR1B1 1931/4885LMNA 2536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.